MPN Research 2024: Emerging Trends
by David Wallace
ASH 2023 Highlights: Patients Are Asking, Episode 3
Discover the latest MPN research from the ASH 2023 conference with MPN expert, Dr. Lucia Masarova. We cover the latest clinical trials, breakthrough treatments, and innovative approaches to MPN blood cancers.
Learn about combination treatments for myelofibrosis and updates on clinical trials for polycythemia vera (PV) and essential thrombocythemia (ET). We are entering a new era of non-JAK2 inhibition with a greater focus on disease modification. Tune in to learn more.
